VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
REVB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
REVBRevelation Biosciences, Inc.
$0.99$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksREVBQuarterly Financials

Revelation Biosciences, Inc. (REVB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Revelation Biosciences, Inc. (REVB) quarterly income statement — complete revenue, gross profit & net income history

REVB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue0000026.96K00037.57K0000000000
Revenue Growth %--100%----28.24%--------------
Cost of Goods Sold7.2K000013.48K7.22K7.22K6.26K18.79K6.26K6.26K6.26K6.26K6.26K6.26K21.22K20.91K20.42K14.7K
COGS % of Revenue-----50%---50%----------
Gross Profit-7.2K000013.48K-7.22K-7.22K-6.26K18.79K-6.26K-6.26K-6.26K-6.26K-6.26K-6.26K-21.22K-20.91K-20.42K-14.7K
Gross Margin %-----50%---50%----------
Gross Profit Growth %--100%100%100%100%-28.24%-15.3%-15.3%0.02%400.02%0%0%70.49%70.05%69.33%57.41%-112.82%---
Operating Expenses3.09M2.57M1.94M2.46M2.09M1.75M1.8M2.52M1.9M2.33M2.78M1.93M1.62M1.22M1.2M1.86M6.59M3.86M3.04M2.44M
OpEx % of Revenue-----6504.55%---6190.16%----------
Selling, General & Admin1.71M1.61M1.02M1.14M1.24M1.15M965.71K1.13M1.18M1.27M1.13M1.02M1.09M878.36K817.9K884.84K2.91M1.19M1.51M1.28M
SG&A % of Revenue-----4258.95%---3369.1%----------
Research & Development1.38M964.19K922.86K1.32M858.83K605.5K830.98K1.39M717.58K1.06M1.65M909.28K525.27K339.97K381.57K975.58K3.68M2.67M1.53M1.16M
R&D % of Revenue-----2245.6%---2821.06%----------
Other Operating Expenses00000000000000000000
Operating Income-3.09M-2.57M-1.94M-2.46M-2.09M-1.75M-1.8M-2.52M-1.9M-2.33M-2.78M-1.93M-1.62M-1.22M-1.2M-1.86M-6.59M-3.86M-3.04M-2.44M
Operating Margin %------6504.55%----6190.16%----------
Operating Income Growth %-47.61%-46.62%-8.14%2.43%-10.14%24.59%35.32%-30.49%-17.43%-90.91%-131.59%-3.9%75.41%68.41%60.6%23.81%-152.57%-33.25%--
EBITDA-3.09M-2.57M-1.94M-2.45M-2.09M-1.75M-1.79M-2.52M-1.9M-2.32M-2.77M-1.93M-1.61M-1.21M-1.19M-1.85M-6.58M-3.85M-3.04M-2.44M
EBITDA Margin %------6477.77%----6173.49%----------
EBITDA Growth %-47.78%-46.89%-8.2%2.43%-10.12%24.7%35.44%-30.54%-17.49%-91.38%-132.29%-3.92%75.48%68.52%60.72%23.95%-152.39%---
D&A (Non-Cash Add-back)7.2K5.85K6.76K7.22K7.22K7.22K7.22K7.22K6.26K6.26K6.26K6.26K6.26K6.26K6.26K6.26K6.26K6.26K6.07K3.81K
EBIT-3.09M-2.57M-1.94M-2.46M-2.09M-1.75M-1.8M-2.52M-1.9M-2.33M-2.78M-1.93M-1.62M-1.22M-1.2M-1.86M-6.59M-3.86M-3.04M-2.44M
Net Interest Income0000000000000028.73K00-41.76K-5570
Interest Income0000000000000028.73K00000
Interest Expense0000000000000000041.76K5570
Other Income/Expense83.45K60.58K35.84K16.85K43.9K28.17K-444.88K-5.87M-779.29K122.99K149.52K484.86K7.78M10.74K28.73K25.73K-30.24K-3.44K-557-27.71K
Pretax Income-3.01M-2.51M-1.91M-2.44M-2.05M-1.73M-2.24M-8.39M-2.68M-2.2M-2.63M-1.45M6.16M-1.21M-1.17M-1.83M-6.62M-3.86M-3.04M-2.47M
Pretax Margin %------6400.09%----5862.84%----------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.01M-2.51M-1.91M-2.44M-2.05M-1.73M-2.24M-8.39M-2.68M-2.2M-2.63M-1.45M6.16M-1.21M-1.17M-1.83M-6.62M-3.86M-3.04M-2.47M
Net Margin %------6400.09%----5862.84%----------
Net Income Growth %-46.71%-45.5%14.92%70.86%23.51%21.66%14.72%-479.34%-143.54%-82.42%-124.51%21.07%193.09%68.72%61.55%25.71%-153.28%-33.37%--
Net Income (Continuing)-3.01M-2.51M-1.91M-2.44M-2.05M-1.73M-2.24M-8.39M-2.68M-2.2M-2.63M-1.45M6.16M-1.21M-1.17M-1.83M-6.62M-3.86M-3.04M-2.47M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.71-1.65-1.77-7.01-2.11-4.98-13.38-82.09-39.37-133.24-200.34-119.60942.76-848.74-934.08-2043.55-7826.95-6569.81-8129.35-6594.34
EPS Growth %-28.44%66.87%86.77%91.46%94.64%96.26%93.32%31.36%-104.18%84.3%78.55%94.15%112.04%87.08%88.51%69.01%-12.18%-121.55%--
EPS (Basic)-2.71-1.65-1.77-7.01-2.11-4.98-13.38-82.09-39.37-133.24-200.34-119.601337.32-848.74-934.08-2043.55-7826.95-6569.81-8129.35-6594.34
Diluted Shares Outstanding3.21M620.8K2.64M802.67K971.31K346.5K167.5K102.2K68.11K16.53K13.12K12.11K6.53K1.42K1.25K898845588375375
Basic Shares Outstanding3.21M620.8K2.64M802.67K971.31K346.5K167.5K102.2K68.11K16.53K13.12K12.11K4.61K1.42K1.25K898845588375375
Dividend Payout Ratio--------------------